ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,681.20
      -2.17%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.225
      0.14%
      Bitcoin
      57,039.92
      -0.54%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Actinium Pharmaceuticals Inc (ATNM)

      7. Actinium Pharmaceuticals Inc (ATNM) News

      ATNM

      Actinium Pharmaceuticals (ATNM)

      Actinium Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:ATNM
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      11/19/20188:00AMPR Newswire (US)Actinium Pharmaceuticals, Inc. to Present at 30th Annual Piper Jaffray Healthcare ConferenceAMEX:ATNMActinium Pharmaceuticals Inc
      11/16/20185:02PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:ATNMActinium Pharmaceuticals Inc
      11/09/20185:05PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ATNMActinium Pharmaceuticals Inc
      11/05/20188:00AMPR Newswire (US)Actinium Pharmaceuticals to Present at BIO-Europe® 24th Annual International Partnering ConferenceAMEX:ATNMActinium Pharmaceuticals Inc
      11/01/20189:01AMPR Newswire (US)Actinium Pharmaceuticals ASH Annual Meeting Presence to Include Oral Presentation of Feasibility and Safety Results of Iomab-...AMEX:ATNMActinium Pharmaceuticals Inc
      10/30/20185:08PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:ATNMActinium Pharmaceuticals Inc
      10/30/20185:05PMPR Newswire (US)Actinium Pharmaceuticals CD33 Program to Focus on Actimab-MDS Pivotal Trial Enabling Study for Targeted Conditioning and Nove...AMEX:ATNMActinium Pharmaceuticals Inc
      10/26/20188:00AMPR Newswire (US)Actinium Pharmaceuticals to Hold Webinar Showcasing Actimab-A Post Phase 2 Trial Plans and Actimab-MDS Regulatory UpdateAMEX:ATNMActinium Pharmaceuticals Inc
      10/24/20188:00AMPR Newswire (US)Actinium Pharmaceuticals Announces Participation at BIO-Europe® 24th Annual International Partnering ConferenceAMEX:ATNMActinium Pharmaceuticals Inc
      10/22/20188:04AMPR Newswire (US)Actinium Pharmaceuticals Announces Webinar Showcasing Actimab-A Post Phase 2 Trial Plans and Actimab-MDS Regulatory UpdateAMEX:ATNMActinium Pharmaceuticals Inc
      10/18/20185:14PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ATNMActinium Pharmaceuticals Inc
      10/18/20185:07PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:ATNMActinium Pharmaceuticals Inc
      10/01/20188:00AMPR Newswire (US)Actinium Launches Iomab-ACT Program Offering Its Targeted, Chemo-Free, Lymphodepletion Technology as a Universal Solution to ...AMEX:ATNMActinium Pharmaceuticals Inc
      09/26/20188:00AMPR Newswire (US)Actinium Pharmaceuticals to Host Webinar Today Introducing Next Generation Targeted Lymphodepletion Technology for CAR-TAMEX:ATNMActinium Pharmaceuticals Inc
      09/20/20188:00AMPR Newswire (US)Actinium Pharmaceuticals to Participate in the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma and Rare DiseaseAMEX:ATNMActinium Pharmaceuticals Inc
      09/18/20188:40AMPR Newswire (US)Actinium Pharmaceuticals to Host Webinar Showcasing New Pipeline Initiative Focused on the CAR-T SpaceAMEX:ATNMActinium Pharmaceuticals Inc
      09/06/20188:00AMPR Newswire (US)Actinium Appoints Robert N. Daly, Ph.D. to Newly Created Role of Vice President, Head of Clinical OperationsAMEX:ATNMActinium Pharmaceuticals Inc
      09/04/20188:00AMPR Newswire (US)Actinium Pharmaceuticals to Present at Upcoming Investor Conferences and Participate in Featured Panel DiscussionsAMEX:ATNMActinium Pharmaceuticals Inc
      08/15/20185:07PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ATNMActinium Pharmaceuticals Inc
      08/09/20185:05PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ATNMActinium Pharmaceuticals Inc
      07/17/20185:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ATNMActinium Pharmaceuticals Inc
      07/17/20185:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ATNMActinium Pharmaceuticals Inc
      07/17/20185:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ATNMActinium Pharmaceuticals Inc
      07/17/20185:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ATNMActinium Pharmaceuticals Inc
      07/17/20185:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ATNMActinium Pharmaceuticals Inc
      07/17/20185:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ATNMActinium Pharmaceuticals Inc
      07/17/20185:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ATNMActinium Pharmaceuticals Inc
      07/17/20185:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ATNMActinium Pharmaceuticals Inc
      06/15/20186:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ATNMActinium Pharmaceuticals Inc
       Showing the most relevant articles for your search:AMEX:ATNM